| 摘要 |
<p>The present invention relates to a composition for preventing or treating an immune disease using human fetal cartilage-derived cells, that can suppress/control an immune response to a tissue transplant. More specifically, the human fetal cartilage-derived cells do not cause an immune response but rather suppress proliferation of activated lymphocytes, control the expression of immune cytokine, which is generated in the activated lymphocytes, and have better proliferation and differentiation capability into a variety of cell tissues compared to adult stem cells, and thus can be useful in regenerating damaged tissue and as an immune control agent for controlling an immune response to a transplant.</p> |
